Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;82:473-481

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Hurtado, M. C. C.
Right arrow Articles by Cingolani, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Hurtado, M. C. C.
Right arrow Articles by Cingolani, H. E.
(Circulation Research. 1998;82:473-481.)
© 1998 American Heart Association, Inc.


Original Contributions

Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium

María C. Camilión de Hurtado, Bernardo V. Alvarez, Néstor G. Pérez, Irene L. Ennis, , Horacio E. Cingolani

From the Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina.

Correspondence to Dr Horacio E. Cingolani, Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Calle 60 y 120, 1900 La Plata, Argentina.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—The effect of angiotensin II (Ang II) on the activity of the cardiac Na+-independent Cl--HCO3- exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride–sensitive increase in pHi in the absence of external HCO3- (HEPES buffer), consistent with its stimulatory action on Na+-H+ exchange (NHE). This alkalinizing effect was not detected in the presence of a CO2-HCO3- buffer (pHi 7.07±0.02 and 7.08±0.02 before and after Ang II, respectively; n=17). Moreover, in Na+-free HCO3-–buffered medium, in which neither NHE nor Na+-HCO3- cotransport are acting, Ang II decreased pHi, and this effect was canceled by previous treatment with SITS. These findings suggested that the Ang II–induced activation of NHE was masked, in the presence of the physiological buffer, by a HCO3--dependent acidifying mechanism, probably the AE. This hypothesis was confirmed on papillary muscles bathed with HCO3- buffer that were first exposed to 1 µmol/L S20787, a specific inhibitor of AE activity in cardiac tissue, and then to 500 nmol/L Ang II (n=4). Under this condition, Ang II increased pHi from 7.05±0.05 to 7.22±0.05 (P<.05). The effect of Ang II on AE activity was further explored by measuring the velocity of myocardial pHi recovery after the imposition of an intracellular alkali load in a HCO3--containing solution either with or without Ang II. The rate of myocardial pHi recovery was doubled in the presence of Ang II, suggesting a stimulatory effect on AE. The enhancement of the activity of this exchanger by Ang II was also detected when the AE activity was reversed by the removal of extracellular Cl- in a Na+-free solution. Under this condition, the rate of intracellular alkalinization increased from 0.053±0.016 to 0.108±0.026 pH unit/min (n=6, P<.05) in the presence of Ang II. This effect was canceled either by the presence of the AT1 receptor antagonist, losartan, or by the previous inhibition of protein kinase C with chelerythrine or calphostin C. The above results allow us to conclude that Ang II, in addition to its stimulatory effect on alkaline loading mechanisms, activates the AE in ventricular myocardium and that the latter effect is mediated by a protein kinase C–dependent regulatory pathway linked to the AT1 receptors.


Key Words: Na+-independent Cl--HCO3- exchanger • AT1 receptor • angiotensin II • myocardial pHi • protein kinase C


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Changes in myocardial pHi can affect a variety of basic cellular functions, including ionic conductances,1 2 metabolic pathways,3 Ca2+ homeostasis,4 5 and myofilament sensitivity to Ca2+.6 In order to ensure strict regulation of pHi, the mammalian myocardium possesses three well-characterized ion-transport systems. The N+-H+ antiporter (NHE) and Na+-HCO3- symport, when activated, induce an intracellular alkalinization,7 8 9 whereas the Na+ independent Cl--HCO3- exchanger (AE) triggers an acidification after an alkaline load.9 10 11 12 Recently, a second acid-loading bicarbonate-independent mechanism has been described.13 In recent years, many studies have been undertaken on the neurohumoral regulation of each of these transporters. The NHE has been the one most extensively investigated in several tissues including the heart.7 14 15 16 17 18 19 20

Ang II is known to regulate myocardial contractility21 and growth.22 The mobilization of Ca2+ and the cardiac hypertrophy occurring under the influence of Ang II stimulation22 23 24 have been shown to involve an activation of the phospholipase C, phospholipase D, and possibly phospholipase A2 pathways.22 25 26 All of these second messenger systems are activated through the AT1 receptor.26 Ang II has been recently shown to increase the activity of two Na+-dependent proton-extruding mechanisms, the NHE17 and the Na+-HCO3- symport, in cardiac muscle.18 19 However, studies on other cells have demonstrated that growth factors (like arginine vasopressin and epidermal growth factor) cause an intracellular acidification in the presence of HCO3- because the stimulatory effect on AE activity is greater than the enhancement of the acid-extruding mechanisms.27 28 In agreement with these observations, we have recently reported that in the presence of the physiological CO2-HCO3- buffer, the positive inotropic effect of Ang II occurs in the absence of any change in pHi.29 The lack of change in myocardial pHi after Ang II in muscles that were exposed to a bicarbonate-containing solution suggested to us that a stimulatory effect on a bicarbonate-dependent acid-loading mechanism was superimposed on the known effect of Ang II on NHE. Therefore, the aim of the present study was to focus on the effect of Ang II on the AE activity in particular and to characterize the nature of the membrane receptor and intracellular signaling pathway through which such an interaction might be mediated.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The experiments were performed in thin cat papillary muscles (mean cross-sectional area, 0.47±0.03 mm2; n=58) dissected from the right ventricle. The animals were anesthetized with pentobarbital sodium (35 mg/kg IP), and the hearts were quickly removed and placed in standard HCO3--buffered solution (see below). The general procedure for dissecting and mounting the muscles has been already described.30 After they were mounted, the muscles were progressively stretched to reach the length at which maximal developed force was obtained. Muscles were paced with square-wave pulses of 10-millisecond duration, and a voltage intensity 10% over threshold was applied via two platinum wires running along the sides of the preparations. Mean developed force of isometric contractions (at the end of the washout period that followed the loading process with the fluorescent probe) was 0.73±0.13 g/mm2. Experiments were performed at 30°C, and the muscles were superfused at a constant flow of 4.0 mL/min with one of the following solutions: (1) The HEPES-buffered solution contained (mmol/L) NaCl 146.2, KCl 4.5, CaCl2 1.35, MgSO4 1.05, glucose 11.0, and HEPES 5.0. pH was adjusted to 7.4 at 30°C with 3 mol/L NaOH (total [Na+], 148.5 mmol/L) and then gassed with 100% O2. (2) HCO3--buffered solutions were equilibrated with a CO2-O2 gas mixture that gave a pH value of 7.39±0.01. The standard HCO3--buffered solution contained (mmol/L) NaCl 128.3, KCl 4.5, CaCl2 1.35, NaHCO3 20.23, MgSO4 1.05, and glucose 11.0. For Na+-free HCO3-–buffered solution, NaCl and NaHCO3 were replaced with equimolar amounts of choline chloride and NMDG, respectively. NMDG · HCO3 was then generated in situ by prolonged ({approx}2-hour) bubbling of the solution with a gas mixture of CO2 in O2 to give a final pH value of 7.40. Cl--free, Na+-free, low-Ca,2+ HCO3--buffered solution contained (mmol/L) NMDG 148.0, MgSO4 1.05, K2SO4 2.25, CaCO3 0.10, aspartic acid 135.0, and glucose 11.0. All the experiments were performed in the presence of 1.0 µmol/L atenolol (Sigma Chemical Co) plus 1.0 µmol/L prazosin (Sigma) in order to prevent adrenoceptor activation by the possible release of catecholamines from nerve endings. Ang II (Sigma) was added to the superfusate in appropriate amounts to give a final concentration of 500 nmol/L. NHE activity was inhibited with EIPA (Research Biochemicals Intl) at 5 µmol/L, whereas SITS (Sigma) was used at 0.1 mmol/L to inhibit AE mechanisms. SITS was dissolved in the superfusate immediately before use, and the solution was protected from light to prevent photodegradation of the drug. CHE (Research Biochemicals Intl) and calphostin C (Research Biochemicals Intl) were used at 10 µmol/L and 50 nmol/L, respectively, as specific inhibitors of PKC.31 32 Losartan, which was used at 10 µmol/L to block the AT1 receptor subtype, was a generous gift of Peter K.L. Siegl from Merck Sharp & Dohme, West Point, Pa. The specific inhibitor of AE activity, S20787,33 was used at 1 µmol/L and was a kind donation of Elizabeth Scalbert from the Institut de Recherches Internationales Servier, Courbevoie, France.

pHi Measurements.
Measurements of pHi in the isolated muscles were made after loading the muscles with the acetoxymethyl ester form of the pH-sensitive dye BCECF (BCECF-AM, Molecular Probes) as previously described.30 BCECF fluorescence was excited at 450 and 495 nm, and the fluorescence emission was monitored after passage through a 535±5-nm filter. To limit photobleaching, a neutral-density filter (1% transmittance) was placed in the excitation light path, and a manual shutter was used to select sampling intervals (for 3 seconds every 15 seconds) during the protocol. At the end of each experiment, fluorescence emission was calibrated by the high K+–nigericin method.34 The calibration solution contained (mmol/L) KCl 140.0, MgCl2 1.0, CaCl2 1.0, HEPES 5.0, nigericin 0.01, sodium cyanide 4.0, and 2,3-butanedione monoxime 20.0 (the last to prevent muscle contracture35 ). Buffer pH was adjusted with KOH to four different values ranging from 7.5 to 6.5. Such a calibration gave a linear relation (r=.99±.003, n=58) between buffer pH values and the fluorescence ratio (F495/F450), with the latter calculated as follows:


The experimental protocols designed for the present study were as follows: basal myocardial pHi was noted after 15 minutes of superfusion with HEPES- or the other HCO-3-buffered solutions indicated above. The muscles were then exposed to Ang II for a further 30 minutes. To study the effect of Ang II on the activity of the AE in its "forward" and "reverse" modes, the muscles were subjected either to intracellular alkaline loads11 13 36 or to the removal of extracellular chloride,16 37 38 respectively.

Intracellular alkalinization was induced by exposing the tissue to TMA (20.0 mmol/L), a technique that has been already validated for the study of the activity of the AE.11 36 The preparations were subjected to two consecutive transient exposures to TMA. After the first alkaline pulse, the muscles were superfused with standard HCO3--buffered solution to allow further recovery of pHi before the second exposure to TMA (second alkaline pulse). As previously reported by several investigators, the initial rate of pHi recovery (dpHi/dti, in pH unit/min) was estimated from the slope of the straight lines fitted to the values of pHi recorded during the first 3 minutes after the peak of alkalosis by linear least squares regression analysis.11 13 36 The correlation coefficient (r) values of the linear fits ranged from .78 to .96. In control experiments, both TMA pulses occurred under identical conditions, and no significant difference in the rate of pHi recovery was detected. When studying the effect of Ang II, the peptide was included in the superfusate 30 minutes before the second pulse to the end of the experiment. Intracellular buffering power (ß) was calculated during the alkaline and acid load of the TMA pulses, in the absence and presence of Ang II, using the following equation:

where {Delta}pHi is the change in pHi measured immediately after the addition or withdrawal of TMA and {Delta}[TMAH+]i was calculated on the basis of the rearrangement of the Henderson-Hasselbach equation:

with the dissociation constant (pK) taken as 9.8. Although the differences did not reach statistical significance, an {approx}20% increase in ß was detected in the presence of Ang II at each pHi analyzed. At a mean pHi of 7.16±0.03, ß values were 58.2±5.9 and 73.2±7.6 mmol/L (n=6, P=NS by paired t test) in the absence and in the presence of Ang II, respectively, whereas values of 53.6±20 and 64.6±16 were determined at 7.43±0.04 (n=6, P=NS by paired t test).

After chloride removal from the extracellular space, the activity of the AE operating in the "reverse" mode was characterized from the initial rate of the increase in pHi immediately after Cl- deprivation. The activity of the Na+-independent AE can be assessed specifically once Na+ is omitted from the Cl--free superfusate. Nevertheless, in order to minimize possible changes in pHi resulting from the entry of either Ca2+ or H+ as the result of the reversal of the Na+-Ca2+ or Na+-H+ exchangers, respectively, these experiments were carried out at low [Ca2+] and in the presence of EIPA. The values of pHi determined during the removal of Cl- were fitted to a straight line (by linear least squares fit of the pHi values recorded during the first 3 minutes37 ) and also to an exponential curve of the form {Delta}pHit={Delta}pHi{infty}(1-e-k{Delta}t), where {Delta}pHit and {Delta}pHi{infty} are the changes in pHi from the initial value at time t and after steady state has been reached, respectively, and k is the rate constant. Even though the r values obtained from the fitting to the exponential curve were higher (r=.86 to .99) than those obtained by linear regression (r=.61 to .98), the initial rate of the changes in pHi (dpHi/dti in pH unit/min) was determined by both procedures. Although a biexponential probably fit better than a monoexponential for the entire curve, the initial rate of the changes in pHi was essentially the same when estimated either with monoexponential or biexponential fits. Mean percent difference between both estimates was 1.25±1.58 (n=28). Two consecutive Cl--removal protocols were carried on the same muscle preparation, the first in the absence and the second in the presence of the specified compounds. The values of dpHi/dti obtained during the first and second protocol were then compared. Previous experiments have shown that dpHi/dti estimated in two successive Cl--removal protocols, under control conditions, did not differ from each other. When the effects of AT1 receptor subtype blockade or PKC activity inhibition were studied, losartan, CHE, or calphostin C were, accordingly, added to superfusate 10 minutes before Ang II. In the experiments with calphostin C, only one Cl--removal protocol was performed, and the results obtained were compared with those in the absence of Ang II, pooling the overall protocols (n=20) under this condition. Neither losartan nor PKC inhibitors produced significant changes in resting pHi.

Statistics
Data are expressed as mean±SEM. Statistical analysis of data was performed by paired t test and ANOVA followed by Bonferroni's test, as appropriate. Probability of null hypothesis <5% (P<.05) was considered significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Action of Ang II on Resting Myocardial pHi
The effect on pHi of various concentrations of Ang II ranging from 10 nmol/L to 1 µmol/L was tested on pilot experiments carried out in HEPES-buffered medium. The magnitude of the effect for a 30-minute exposure to Ang II was related to its concentration in the superfusate. The Ang II–induced rise in pHi was maximal at a concentration of 1 µmol/L; 30% and 96% of the maximal effect was obtained with 10 and 500 nmol/L, respectively. In accordance with data reported by other investigators,19 21 39 the maximal inotropic effect was obtained with 500 nmol/L Ang II. Although this concentration seems to be higher than reported values in extracellular fluids,25 40 it was chosen for all the experiments because it was, in the absence of bicarbonate, eliciting the maximal contractile response and nearly the maximal increase in pHi.

The steady-state pHi is determined by the balance between processes that load cells with acid equivalents and those that extrude them. In the absence of a CO2-HCO3- buffer system, the only substantial acid-extruding mechanism is NHE. Fig 1ADown illustrates an experiment in which a papillary muscle, superfused with a nominal HCO3--free (HEPES) buffer, was exposed to 500 nmol/L Ang II. As shown in Fig 1ADown, pHi began to increase after 12 minutes of exposure to the peptide, reaching a value 0.11 U more alkaline than the initial one after 30 minutes. Fig 1BDown shows mean values of basal pHi and those after 30 minutes of exposure to Ang II in HEPES-buffered medium (n=4).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Effect of Ang II on myocardial pHi in nominally HCO3--free (HEPES) buffer. A, The data are from a representative experiment showing the time course of the effect of Ang II on resting pHi. B, The mean±SEM values obtained from all the experiments (n=4) both before (basal) and after 30 minutes of exposure to Ang II at 500 nmol/L are shown. The significance of the difference between the basal and Ang II–stimulated pHi values was assessed by paired t test.

The results shown in Fig 2Down confirm that the increase in pHi elicited by Ang II in the absence of HCO3- resulted from the stimulation of NHE. The blockade of NHE activity by 5 µmol/L EIPA prevented the increase in pHi induced by Ang II (n=6). Indeed, when the NHE was inhibited in nominal HCO3--free solution, a slight but significant decrease in pHi was detected. A similar decline in pHi after exposure to Ang II in the absence of NHE activity was previously observed by several authors and was attributed to a metabolic effect of Ang II.17 41



View larger version (23K):
[in this window]
[in a new window]
 
Figure 2. Prevention of the alkalinizing effect of Ang II in HEPES buffer by blockade of NHE. A, The data are from a representative experiment showing the suppression of the alkalinizing effect of Ang II in the presence of the specific NHE inhibitor, EIPA. Here, instead of the increase in pHi observed in Fig 1Up, a slight acidification was induced by Ang II under these conditions. B, The mean±SEM values obtained from all the experiments (n=6) both before (basal) and after 30 minutes of exposure to Ang II at 500 nmol/L in the presence of 5 µmol/L EIPA are shown. The significance of the difference between the basal and Ang II–stimulated pHi values was assessed by paired t test.

With HCO3- present in the superfusate, however, the same dose of Ang II was followed by no significant changes in myocardial pHi (Fig 3ADown). Here, the fact that no significant increase in pHi could be detected despite the stimulatory effect of Ang II on the NHE suggested the possibility of a simultaneous enhancement of a bicarbonate-dependent acidifying mechanism. The possibility that Ang II depressed the activity of the Na+-HCO3- symport and blunted the increase in pHi is unlikely, since the cotransporter has been shown to be stimulated by the peptide.18 19



View larger version (25K):
[in this window]
[in a new window]
 
Figure 3. Absence of alkalinizing effect of Ang II in the presence of the physiological CO2-HCO3- buffer. A, The data show the time course of the effect of Ang II on pHi in a representative experiment performed on a papillary muscle superfused with CO2-HCO3- buffer. B, The mean±SEM values obtained from all the experiments (n=17) before (basal) and after 30 minutes of exposure to Ang II at 500 nmol/L are shown.

Fig 4Down shows the effect of Ang II when examined in HCO3- buffer after the blockade of NHE activity with EIPA. A slight transitory decrease in pHi followed by a return to baseline was detected in each of the seven experiments. Although these results are difficult to interpret, a reasonable hypothesis would be that Ang II stimulated AE activity (thereby decreasing pHi), which was then followed by a recovery mediated through activation of Na+-HCO3- cotransport. The stimulation of symport activity could have been triggered by the fall in pHi and/or a stimulatory effect of Ang II on this mechanism.18 19



View larger version (19K):
[in this window]
[in a new window]
 
Figure 4. Effect of Ang II on myocardial pHi in HCO3- buffer after the inhibition of NHE activity. A slight transitory decrease in pHi followed by a return to baseline value was observed after the application of 500 nmol/L Ang II to muscles superfused with HCO3- buffer containing 5 µmol/L EIPA (n=7). Inset shows values of pHi before (basal) and after 30 minutes of exposure to Ang II. *P<.05 vs baseline.

The experiments shown in Fig 5Down give further support to the hypothesis of a stimulatory effect of Ang II on AE activity. In this series of experiments, the effect of Ang II in Na+-free HCO3-–buffered medium was examined. In order to minimize the progressive decrease in pHi that could result from background acid loading in the absence of external Na+, the muscles were exposed to Na+-free solutions only for a short period ({approx}15 minutes). Under this condition, in which neither NHE nor the symport was operative, the application of Ang II resulted in a clear decrease in pHi, indicating that the peptide stimulated a Na+-independent HCO3--dependent acidifying mechanism (Fig 5Down). Moreover, this acidifying effect of Ang II in Na+-free HCO3-–buffered solution was abolished by pretreatment of the preparations with SITS (average {Delta}pHi being 0.008±0.02, n=4). Although the magnitude of the decrease in pHi was similar to the one obtained when NHE activity was blocked in HEPES buffer, it should be considered that in the presence of HCO3-, the total buffer capacity is increased, attenuating any change in pHi for a given acid equivalent flux.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 5. Effect of Ang II on myocardial pHi in Na+-free HCO3- buffer. A, The data are from a representative experiment showing an acidifying effect of Ang II in the absence of external Na+ ions. B, The mean±SEM values obtained from all the experiments (n=5) both before (basal) and after 30 minutes of exposure to Ang II at 500 nmol/L are shown. The significance of the difference between the basal and Ang II–stimulated pHi values was assessed by paired t test.

The previous results show that in the presence of extracellular HCO3-, Ang II stimulation of NHE activity was counteracted by an acidifying mechanism that was SITS sensitive and independent of external Na+. This bicarbonate-dependent acid loading was probably mediated by AE activity. Perhaps the strongest evidence of the stimulatory effect of Ang II on the AE is apparent in the results shown in Fig 6Down. In these experiments, the effect of Ang II in HCO3--buffered medium was assessed in the presence of S20787, a recently described specific inhibitor of AE activity.33 Under this condition, an increase in pHi was detected after application of Ang II. The blockade of AE activity seemed, therefore, to unmask an Ang II–induced stimulatory effect on the alkaline loaders and resulted in clearly apparent intracellular alkalinization. The effectiveness of S20787 as an inhibitor of AE activity was tested in parallel experiments that proved that S20787 at 1 µmol/L reduced by 67±12% the rate of pHi recovery from an intracellular alkaline load without altering steady-state pHi value (n=3, data not shown). These results are in agreement with those previously reported by Lagadic-Gossmann et al.33



View larger version (28K):
[in this window]
[in a new window]
 
Figure 6. Ang II increases pHi in CO2/HCO3- buffer in the presence of a specific inhibitor of AE activity. A, The data are from a representative experiment showing the alkalinizing effect of Ang II in the presence of S20787, a specific inhibitor of AE activity. B, The mean±SEM values obtained from all the experiments (n=4) both before (basal) and after 30 minutes of exposure to Ang II at 500 nmol/L are shown. The significance of the difference between the basal and Ang II–stimulated pHi values was assessed by paired t test. At the concentration used (1 µmol/L), S20787 did not change the steady-state pHi. In accordance with previously reported data,32 this concentration of S20787 inhibited by {approx}70% the activity of AE as measured by the rate of recovery from intracellular alkalinization in control experiments (n=3).

To further explore the effect of Ang II on AE activity, the following experiments, in which the exchanger was activated while operating in its "forward" and "reverse" modes, were designed.

Action of Ang II on the Activity of the AE After an Intracellular Alkaline Load
During intracellular alkalosis, a recovery of pHi resulting from an extrusion of intracellular HCO3- ions in exchange for extracellular Cl- can be detected, regardless of the technique used to increase pHi.10 11 12 Exposure to TMA has been previously demonstrated to be a valid technique for investigating the activity of the AE because no recovery from TMA-induced intracellular alkalosis is detected in HCO3--free solutions.11 42 Papillary muscles were exposed to TMA, and the velocity of the recovery of pHi was measured before and after Ang II as an indication of the activity of the AE. Fig 7Down shows the results of one of six similar experiments. Under control conditions (Fig 7ADown), pHi rose rapidly from a steady-state value of 7.00 to 7.51 after exposing the tissue to TMA. The intracellular alkalosis was followed by a recovery in pHi due to the activity of the AE. The rate of pHi recovery from the intracellular alkaline load was enhanced in the presence of Ang II (Fig 7BDown). On average, in these experiments, exposure to TMA increased pHi from 7.12±0.04 to 7.49±0.06, and the average rate of pHi recovery was 0.009±0.003 pH unit/min in the absence of Ang II (n=6). In the presence of Ang II, TMA caused an elevation in pHi from 7.12±0.03 to 7.46±0.05, but even though the alkaline load was of a magnitude similar to that under control conditions, the velocity of pHi recovery was increased to 0.018±0.004 pH unit/min (P<.05 by paired t test), suggesting an enhanced HCO3- efflux. However, it should be also considered that the higher rate of recovery could be merely the result of a decrease in buffering power induced by Ang II. Buffer capacity was estimated as explained in "Materials and Methods," and although {approx}20% of increase in ß was detected in the presence of Ang II, the difference did not reach statistical significance. Therefore, changes in dpHi/dti were considered to be proportional to changes in bicarbonate fluxes.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 7. Effect of Ang II on the recovery of pHi after an intracellular alkaline load. The data are from a representative experiment among the six performed. Intracellular alkalosis was imposed by rapid addition of TMA (20.0 mmol/L) to HCO3--buffered superfusate. A, The sudden TMA-induced elevation in pHi is followed by a gradual recovery of pHi. The rate of the pHi recovery was estimated by the slope of the line fitted by least squares method to the values of pHi after the peak of TMA-induced alkalosis (broken line). B, The same protocol as in panel A was used, except that 500 nmol/L Ang II was applied 30 minutes before the TMA pulse. In the presence of Ang II, a marked increment in the rate of pHi recovery from alkalosis was detected. In control experiments, we showed that the rates of pHi recovery were the same in two consecutive TMA pulses (see "Materials and Methods").

Action of Ang II on the Activity of the AE Operating in the Reverse Mode
When myocardial tissue is suddenly subjected to the removal of extracellular Cl-, pHi rises because of the influx of HCO3- resulting from the reversal of AE activity. To measure specifically the activity of this AE, the removal of Cl- was performed in Na+-free solutions. Moreover, the [Ca2+] in this solution had been lowered to prevent possible pHi shifts resulting from changes in [Ca2+]i, and the blockade of NHE was also achieved using EIPA so as to prevent a possible reversal of the antiporter.11 43 Under Cl--free conditions, the activity of the AE could then be estimated from the initial velocity of alkalinization (dpHi/dti) as used before by other investigators.37 38 43

Fig 8ADown shows the changes in pHi obtained in a typical experiment after Cl- removal with a muscle kept in Na+-free medium for a period longer than an hour, either in the absence (left) or in the presence of Ang II (right). Under these experimental conditions, the removal of extracellular Cl- caused an alkalinization that was readily reversed on readdition of Cl-. Since extracellular Na+ was absent in these experiments, the mechanism that produced this alkalinization must have been Na+ independent. The theoretical curves obtained by the exponential fits are shown superimposed to the pHi tracings in Fig 8ADown. Fig 8BDown shows the initial rates of intracellular alkalinization induced by Cl- removal estimated by these fittings (initial pHi values were 6.94±0.04 and 6.92±0.03 in the absence and presence of Ang II, respectively; n=4). Ang II accelerated the initial rate of alkalinization induced by Cl- removal in the absence of Na+. The acceleration induced by Ang II in the rate of alkalinization was also noted when it was determined by the fitting of the pHi values recorded after Cl- removal to a straight line (instead of the exponential fitting). In this case, the rate of Cl- removal–induced alkalinization increased from a control value of 0.011±0.007 to 0.019±0.002 pH unit/min under Ang II (P<.05 by paired t test).



View larger version (31K):
[in this window]
[in a new window]
 
Figure 8. Stimulation by Ang II of the activity of AE operating in "reverse mode." The activity of the anion exchanger was reversed into a mode of intracellular Cl-–extracellular HCO3- exchange by exposure of the myocardium to Cl--free superfusate. The superfusate was also made Na+ free to ensure the Na+ independence of the exchange activity being assayed, and it also contained low Ca2+ (100 µmol/L) and EIPA (5 µmol/L) to eliminate the possible influence of Na+-H+ and Na+-Ca2+ exchanger reversal in a Na+-free milieu. A, Results from a representative experiment in which the preparation was superfused with Na+-free medium for {approx}60 minutes before the first Cl- removal (left, no Ang II in the medium). The Cl- removal protocol was repeated after 30 minutes of exposure to 500 nmol/L Ang II (right). Experimental data were fitted to an exponential curve of the form {Delta}pHit={Delta}pHi{infty}(1-e-k{Delta}t) (where {Delta}pHit and {Delta}pHi{infty} are the changes in pHi from the initial value at time t and after steady state has been reached, respectively, and k is the rate constant) to estimate the initial velocity of the rise in pHi (dpHi/dti in pH unit/min) as explained in "Materials and Methods." The theoretical curves corresponding to each set of data are shown; the correlation coefficient (r) values were .93 and .98, without and with Ang II, respectively. B, Mean dpHi/dti value±SEM obtained from the overall experiments (n=4) in Na+-deprived medium. C, Results from a representative experiment in which Na+ withdrawal was effected simultaneously to Cl- removal, in the absence (left) and after exposing the muscle to Ang II for 30 minutes (right). The theoretical curves obtained by exponential fit of each set of data are shown, and their corresponding r values were .92 and .99 without and with Ang II. D, Mean values of initial rate of alkalinization induced by Cl- removal in the experiments under the conditions indicated in panel C (n=6). The significance of the differences between values of dpHi/dti values before and after Ang II was assessed by the paired t test. Note that Ang II significantly increased the rate of intracellular alkalinization, regardless of whether Na+ deprivation was before or simultaneous with Cl- withdrawal.

Fig 8CUp shows the results from a representative experiment in which Na+ and Cl- were simultaneously removed in order to minimize the induction of intracellular acidosis and a consequent inactivation of AE.10 38 44 The theoretical curves obtained by the exponential fits are, like in Fig 8AUp, shown superimposed to the pHi tracings. The average values of the initial rate of alkalinization estimated in the experiments of this group are illustrated in Fig 8DUp. Ang II increased the initial rate of alkalinization induced by the removal of external Cl- (baseline pHi was 7.07±0.04 and 7.08±0.04 in the absence and presence of Ang II, respectively; n=6). The effect of Ang II was also detected when the initial rate of pHi change was estimated by fitting the data to a straight line. Mean value was 0.045±0.01 pH unit/min in the absence of Ang II, and it increased to 0.077±0.02 pH unit/min in the presence of Ang II (n=6, P<.05 by paired t test).

Ang II was, then, showing a stimulatory effect on the AE working in reverse mode under rigorous Na+-free conditions and also when Na+ and Cl- deprivation were simultaneously performed. The initial rate of alkalinization, the extent of alkalinization, and the magnitude of the changes induced by Ang II after prolonged Na+ deprivation were, however, only about half of those observed when Na+ deprivation was simultaneous with Cl- withdrawal. This raises the question of whether the increased activity and responsiveness of the AE under less strict Na+ deprivation is due to (1) the presence of residual Na+ stimulating a Na+-dependent Cl--HCO3- exchange or (2) the higher pHi, which stimulates AE activity. This question was addressed by Boyarsky et al38 who showed that in renal mesangial cells the increase in pHi following the removal of Cl- is mediated by the AE, regardless of whether the experiments were carried out in the presence or absence of Na+.38 The authors demonstrated that the reduction in intracellular alkalinization evoked by Cl- removal after Na+ deprivation was only reflecting the inhibition of AE activity by low pHi, as previously reported.10 44 If, in addition, we consider that a Na+-dependent Cl--HCO3- exchange has not been demonstrated in adult cardiac myocytes,8 it is very likely that Na+ deprivation is not necessary to assess AE activity after Cl- removal.

After demonstrating that the activation of AE activity by Ang II could be detected by Cl- deprivation in the absence of Na+ and when Na+ deprivation was simultaneous with the removal of Cl-, we used the same protocol as shown in Fig 8CUp to assess the subtype of AT receptor involved and the possible role played by PKC activity. Fig 9ADown shows one of four similar experiments in which losartan (10 µmol/L) was included in the superfusate before testing the effect of Ang II. The Ang II–induced increase in the rate of intracellular alkalinization following Cl- removal was eliminated when the AT1 receptors were blocked. The mean values of dpHi/dti under basal conditions (no drugs) and in the presence of losartan and Ang II plus losartan are shown in Fig 9BDown. Blockade of AT1 receptors with losartan did not change the rate of intracellular alkalinization induced by Cl- removal and canceled the acceleration induced by Ang II (Fig 9BDown). The suppression by losartan of the effects of Ang II was also detected when dpHi/dti values were determined by linear regression (0.045±0.02 versus 0.044±0.01 pH unit/min, n=4).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 9. Involvement of the AT1 receptor subtype in the stimulation of AE by Ang II. A, Experimental conditions are the same as those in Fig 8CUp except that losartan (Los), a specific antagonist of AT1 receptor subtype, was added (10 µmol/L) 10 minutes before Ang II. The pHi values obtained in a representative experiment with the same papillary muscle before (left) and after exposure to Ang II+Los (right) are depicted as a function of time. The theoretical exponential curves fitted to the experimental data are shown; the r values were .86 and .88 in the absence and presence of Ang II, respectively. B, Mean dpHi/dti values were obtained in the control condition (no drugs present, n=8), in the presence of 10 µmol/L Los (n=4), and in the presence of Los+Ang II (n=4). No significant difference in the rate of intracellular alkalinization induced by Cl- removal was detected when Los or Los+Ang II was added (ANOVA).

In order to gain further insight into the mechanism by which Ang II enhances the activity of the AE, experiments similar to those described in Figs 8CUp and 9AUp were performed but in the presence of the selective PKC inhibitor, CHE. Fig 10ADown presents the results of a representative experiment in which, like the preceding experiments, the preparations were subjected to Cl- deprivation first in the absence of Ang II (left) and then in the presence of Ang II and CHE (right). Fig 10BDown shows the initial rate of changes in pHi induced by Cl- removal under control conditions and in the presence of CHE or Ang II plus CHE. PKC inhibition by CHE decreased the initial rate of alkalinization. Application of Ang II in the presence of CHE did not significantly change the initial rate of alkalinization (Fig 10BDown) compared with the control value or with CHE without Ang II (ANOVA). Then, the acceleration in the initial rate of alkalinization seen with Ang II alone was no longer detected in the presence of the PKC inhibitor, either when estimated by linear (0.0395±0.007 versus 0.0330±0.008 pH unit/min, n=4) or exponential fittings (Fig 10BDown). A similar suppression of the effects of Ang II on the activity of the AE was also obtained when another structurally and mechanistically different inhibitor of PKC activity, calphostin C, was used. Under this condition, the initial rate of alkalinization estimated with the exponential fit was 0.0344±0.007 pH unit/min and with the linear fit was 0.017±0.005 pH unit/min (n=4, P<.05 compared with Ang II and not significantly different from control by ANOVA).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 10. Abolition of Ang II–induced stimulation of AE through inhibition of PKC activity. Experimental conditions are the same as those stated in Figs 8CUp and 9AUp except that the specific inhibitor of PKC activity, CHE (10 µmol/L), was added 10 minutes before Ang II. A, The pHi values obtained with the same papillary muscle before (left) and after exposure to Ang II+CHE (right) are depicted as a function of time. The theoretical exponential curves fitted to the experimental data are shown, and the r values were .98 for both curves. B, Mean dpHi/dti values were obtained under control conditions (no drugs added, n=8), in the presence of CHE (n=4), and in the presence of CHE+Ang II (n=4). Inhibition of PKC activity decreased the velocity of intracellular alkalinization after Cl- removal and canceled the acceleration induced by Ang II. *P<.05 vs control (ANOVA).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
An increase in pHi resulting from the activation of NHE by Ang II was observed in the absence of bicarbonate. However, when bicarbonate was present, we were unable to detect any significant change in pHi after Ang II. The lack of any detectable alkalinization in the presence of bicarbonate, being NHE operative, suggested that the activation of AE by Ang II was a strong possibility. The following pieces of evidence gave further support to this hypothesis: (1) when AE activity was specifically inhibited, Ang II induced a rise of myocardial pHi in the presence of bicarbonate; (2) when in the presence of bicarbonate, the alkaline loaders (NHE and Na+-HCO3- symport) were rendered quiescent by Na+ deprivation, Ang II induced a decrease in myocardial pHi that reflected its stimulatory effect on AE activity; (3) when AE activity was challenged by an intracellular alkaline load (a maneuver validated to assess the activity of this exchanger), Ang II enhanced the velocity of pHi recovery; and (4) Ang II increased the rate of intracellular alkalinization due to the reversal of AE activity that follows the removal of Cl- from bicarbonate-buffered solutions.

Ang II can bind to at least two different types of receptors, referred to as AT1 and AT2.45 The ability of losartan to block the stimulation of the AE would indicate that the effect of Ang II on the AE is mediated by the AT1 receptor subtype. This finding is consistent with recent reports indicating that most of the effects of Ang II on heart muscle involve the participation of AT1 receptors.19 21 22 25 26 Nevertheless, the action of Ang II on Na+-HCO3- cotransport in cultured neonatal rat ventricular myocytes has been found to occur through binding to receptors of the AT2 subtype.18 However, it is important to emphasize that the AT2 receptor subtype is only transiently expressed in the neonatal rat heart.46

AT1 receptors belong to the class of seven transmembrane domain receptors coupled to G regulatory proteins, and their activation by Ang II involves a number of intracellular second messengers. Ang II stimulates phospholipase C, resulting in a subsequent hydrolysis of phosphatidylinositol 4,5-bisphosphate and the formation of inositol 1,4,5-trisphosphate and diacylglycerol. Ang II has also been shown to activate the mitogen-activated protein kinase pathway.47 Therefore, Ang II, like other humoral stimuli known to act through receptors coupled to Gq regulatory proteins, stimulates multiple intracellular phosphotransferase reactions mediated by both PKC-dependent and PKC-independent pathways.24 47 Furthermore, evidence had been presented showing that the NH2-terminal domain of the AE3 protein expressed in brain and heart plays a regulatory role in the activity of the AE,48 and Yannoukakos et al49 noted that the AE3 isoform of cardiac muscle contains several potential PKC consensus phosphorylation sites. Ludt et al50 reported that in Vero cells downregulation of PKC was followed by a change in the sensitivity of the AE to intracellular proton concentration. Our observation that the inhibition of PKC canceled the stimulatory effect of Ang II on the AE activity would further suggest that its action very likely involves a PKC-dependent phosphorylation of the exchanger-protein molecule itself.

Studies on other cells have demonstrated that growth factors (eg, arginine vasopressin and epidermal growth factor) raise pHi by stimulating the NHE. However, in the presence of bicarbonate, growth factors cause an acidification because the stimulatory effect on AE activity is greater than the enhancement of the acid-extrusion mechanisms.27 28 We now show that another growth factor, Ang II, activates the AE of the heart, operating in either the forward or the reverse mode. During the course of the present experiments on cat myocardium, we were aware, by a preliminary communication, that Ang II was shown to have a stimulatory effect on the activity of AE in the perfused ferret heart.51 However, a more recent study by the same authors reported a lack of action of Ang II on the activity of the AE in the same preparation.19

The AE, in addition to mediating the Cl- "shift" in erythrocytes,52 operates as an alkali extruder that regulates pHi in diverse tissues, including lymphocytes,53 smooth muscle cells,54 and myocardium.10 11 16 In cardiac muscle, the AE may be an important mechanism for maintaining [Cl-]i above the level otherwise obtained at electrochemical equilibrium.49 55 Cl- channels, which may also contribute to the regulation of [Cl-]i, have been shown to be activated by Ang II in cardiomyocytes.56

We conclude that Ang II enhances the activity of the AE in ventricular myocardium and that this effect is mediated by the AT1 receptor subtype and involves a PKC-dependent regulatory pathway. The fact that in the presence of bicarbonate no changes in myocardial pHi were detected in our experiments does not argue against an increase in [Na+]i due to stimulation of NHE in the presence of Ang II. The increase in [Na+]i may still be present even if the effects of the increased activity of NHE on pHi were blunted by the enhanced activity of the AE. This [Na+]i increase will lead to a secondary increase in [Ca2+]i through the Na+-Ca2+ exchanger mechanism, and this may contribute to the positive inotropic effect of Ang II. However, the effect of Ang II on the amplitude of Ca2+ transients is controversial,41 57 58 and a synergistic action of [Ca2+]i and pHi in mediating the inotropic effect of Ang II has been proposed.39

A novel acid-loading mechanism has been recently reported.12 This mechanism was proposed to exchange extracellular Cl- for intracellular OH- or, alternatively, to be an H+-Cl- symport. Whether Ang II can activate this novel mechanism through a PKC-dependent pathway was not analyzed by us. However, this possibility seems unlikely if we consider that this novel mechanism is bicarbonate independent.

The Ang II–induced increase in pHi is not observed in the presence of HCO3- despite suggestions that the rise in pHi may be a growth signal.59 60 It would be advantageous, however, for the activated myocyte to maintain a steady-state pHi within the normal limits but to be able to recover more rapidly from acid and alkali loads. This will be made possible through the simultaneous activation of one alkaline and one acid loader mechanism. The hypothesis that an important physiological effect of the growth factors may be to maintain a near normal pHi while stimulating several acid-base transporters was proposed in 1989 by Boron et al.28 This view was based on experiments studying the effects of arginine vasopressin on renal mesangial cells, and after our findings, it can be extended to the effect of Ang II on myocardium. These findings also emphasize the fact that although HEPES buffer might be a useful experimental tool, conclusions concerning the physiological processes must be drawn from experiments using a CO2-HCO3- buffer–containing saline solution.9


*    Selected Abbreviations and Acronyms
 
AE = anionic exchange(r)
Ang II = angiotensin II
CHE = chelerythrine chloride
EIPA = 5-(N-ethyl-N-isopropyl)amiloride
NHE = Na+-H+ exchange(r)
NMDG = N-methyl-D-glucamine
PKC = protein kinase C
TMA = trimethylamine hydrochloride


*    Acknowledgments
 
B.V. Alvarez was the recipient of a predoctoral fellowship from Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina. I.L. Ennis was the recipient of a predoctoral fellowship from La Plata University, Argentina. Dr Pérez was the recipient of a postdoctoral fellowship from Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina. Drs Camilión de Hurtado and Cingolani are Established Investigators of Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina. The authors thank Karen Mesa Noack for her excellent secretarial assistance during the preparation of the manuscript.

Received February 28, 1997; accepted December 19, 1997.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Kohlhardt M, Haap K, Figulla HR. Influence of low extracellular pH upon the Ca inward current and isometric contractile force in mammalian ventricular myocardium. Pflugers Arch. 1976;366:31–38.[Medline] [Order article via Infotrieve]

2. Fry CH, Poole-Wilson PA. Effect of acid-base changes on excitation-contraction coupling in guinea-pig and rabbit cardiac ventricular muscle. J Physiol (Lond). 1981;313:141–160.[Abstract/Free Full Text]

3. Schaffer SW, Safer B, Ford C, Illingworth J, Williamson JR. Respiratory acidosis and its reversibility in perfused rat heart: regulation of citric acid cycle activity. Am J Physiol. 1978;234(Heart Circ Physiol 3):H40–H51.

4. Orchard CH, Kentish JC. Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol. 1990;258(Cell Physiol 27):C967–C981.

5. Kusuoka H, Backx PH, Camilión de Hurtado MC, Azan-Backx M, Marban E, Cingolani HE. Relative roles of intracellular Ca2+ and pH in shaping myocardial contractile response to acute respiratory alkalosis. Am J Physiol. 1993;265(Heart Circ Physiol 34):H1696–H1703.

6. Fabiato A, Fabiato F. Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiac and skeletal muscles. J Physiol (Lond). 1978;276:233–255.[Abstract/Free Full Text]

7. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:1029–1042.[Medline] [Order article via Infotrieve]

8. Dart C, Vaughan-Jones RD. Na+-HCO-3 symport in the sheep cardiac Purkinje fibre. J Physiol (Lond). 1992;451:365–385.[Abstract/Free Full Text]

9. Thomas RC. Cell growth factors. Bicarbonate and pHi response. Nature. 1989;337:601.[Medline] [Order article via Infotrieve]

10. Vaughan-Jones RD. Chloride-bicarbonate exchange in sheep cardiac Purkinje fibre. In: Nuccitelli R, Deamer D, eds. Intracellular pH, Its Measurements, Regulation and Utilization in Cellular Functions. New York, NY: Alan R Liss Inc; 1982:239–252.

11. Xu P, Spitzer W. Na+-independent Cl--HCO3- exchange mediates recovery of pHi from alkalosis in guinea pig ventricular myocytes. Am J Physiol. 1994;267(Heart Circ Physiol 36):H85–H91.

12. Sun B, Leem CH, Vaughan-Jones RD. Novel chloride-dependent acid loader in the guinea-pig ventricular myocyte: part of a dual acid-loading mechanism. J Physiol (Lond). 1996;495:65–82.[Abstract/Free Full Text]

13. Pucéat M, Clément O, Vassort G. Extracellular MgATP activates the Cl-/HCO3- exchanger in single rat cardiac cells. J Physiol (Lond). 1991;444:241–256.[Abstract/Free Full Text]

14. Gambassi G, Spurgeon HA, Lakatta EG, Blank PS, Capogrossi MC. Different effects of {alpha}- and ß-adrenergic stimulation on cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes. Circ Res. 1992;71:870–882.[Abstract/Free Full Text]

15. Lagadic-Gossmann D, Vaughan-Jones RD. Coupling of dual acid extrusion in the guinea-pig ventricular myocyte to {alpha}1- and ß-adrenoceptor. J Physiol (Lond). 1993;464:49–73.[Abstract/Free Full Text]

16. Désilets M, Pucéat M, Vassort G. Chloride dependence of pH modulation by ß-adrenergic agonist in rat cardiomyocytes. Circ Res. 1994;75:862–869.[Abstract/Free Full Text]

17. Matsui H, Barry WH, Livsey C, Spitzer KW. Angiotensin II stimulates sodium-hydrogen exchange in adult rabbit ventricular myocytes. Cardiovasc Res. 1995;29:215–221.[Medline] [Order article via Infotrieve]

18. Kohout TA, Rogers TB. Angiotensin II activates Na+/HCO3- symport through a phosphoinositide-independent mechanism in cardiac cells. J Biol Chem. 1995;270:20432–20438.[Abstract/Free Full Text]

19. Grace AA, Metcalfe JC, Weissberg PL, Bethell HWL, Vanderberg JI. Angiotensin II stimulates sodium-dependent proton extrusion in perfused ferret heart. Am J Physiol. 1996;270(Cell Physiol 39):C1687–C1694.

20. Korichneva I, Pucéat M, Millanvoye-Van Brussel E, Géraud G, Vassort G. Aldosterone modulates both the Na/H antiport and Cl/HCO3 exchanger in cultured neonatal rat cardiac cells. J Mol Cell Cardiol. 1995;27:2521–2528.[Medline] [Order article via Infotrieve]

21. Ishihata A, Endoh M. Pharmacological characteristics of the positive inotropic effect of angiotensin II in the rabbit ventricular myocardium. Br J Pharmacol. 1993;108:999–1005.[Medline] [Order article via Infotrieve]

22. Schunkert H, Sadoshima J, Cornelius T, Kagaya Y, Weinberg EO, Izumo S, Riegger G, Lorell BH. Angiotensin II–induced growth responses in isolated adult rat hearts: evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res. 1995;76:489–497.[Abstract/Free Full Text]

23. Berk BC, Aronow MS, Brock TA, Cragoe E, Gimbrone MA, Alexander RW. Angiotensin II-stimulated Na+/H+ exchange in cultured vascular smooth cells: evidence for protein kinase C-dependent and -independent pathways. J Biol Chem. 1987;262:5057–5064.[Abstract/Free Full Text]

24. Baker KM, Booz GW, Dostal DE. Cardiac action of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;54:227–241.[Medline] [Order article via Infotrieve]

25. Sadoshima J, Izumo S. Molecular characterization of angiotensin II–induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res. 1993;73:413–423.[Abstract/Free Full Text]

26. Sadoshima J, Izumo S. Signal transduction pathways of angiotensin II–induced c-fos gene expression in cardiac myocytes in vitro: roles of phospholipid-derived second messengers. Circ Res. 1993;73:424–438.[Abstract/Free Full Text]

27. Ganz MB, Boyarsky G, Sterzel RB, Boron WF. Arginine vasopressin enhances pHi regulation in the presence of HCO3- by stimulating three acid-base transport systems. Nature. 1989;337:648–651.[Medline] [Order article via Infotrieve]

28. Boron WF, Boyarsky G, Ganz M. Regulation of intracellular pH in renal mesangial cells. Ann N Y Acad Sci. 1989;574:321–332.[Medline] [Order article via Infotrieve]

29. Mattiazzi A, Perez NG, Vila-Petroff MG, Alvarez B, Camilión de Hurtado MC, Cingolani HE. Dissociation between the positive inotropic and alkalinizing effects of angiotensin II in feline myocardium. Am J Physiol. 1997;272(Heart Circ Physiol 41):H1131–H1136.

30. Camilión de Hurtado MC, Pérez NG, Cingolani HE. An electrogenic sodium-bicarbonate cotransport in the regulation of myocardial intracellular pH. J Mol Cell Cardiol. 1995;27:231–242.[Medline] [Order article via Infotrieve]

31. Herbet JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993–997.[Medline] [Order article via Infotrieve]

32. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C, a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1989;159:548–553.[Medline] [Order article via Infotrieve]

33. Lagadic-Gossmann D, Le Prigent K, Le Baut G, Caignard DH, Renard P, Scalbert E, Feuvray D. Effects of S20787 on pHi-regulating mechanisms in the rat isolated ventricular myocyte. J Cardiovasc Pharmacol. 1996;28:547–552.[Medline] [Order article via Infotrieve]

34. Thomas JA, Buchsbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry. 1979;18:2210–2218.[Medline] [Order article via Infotrieve]

35. Borzak S, Kelly RA, Kramer BK, Matoba Y, Marsh JD, Reers M. In situ calibration of fura-2 and BCECF fluorescence in adult rat ventricular myocytes. Am J Physiol. 1990;259(Heart Circ Physiol 28):H973–H981.

36. Pérez NG, Alvarez BV, Camilión de Hurtado MC, Cingolani HE. pHi regulation in myocardium of the spontaneously hypertensive rat: compensated enhanced activity of the Na+-H+ exchanger. Circ Res. 1995;77:1192–1200.[Abstract/Free Full Text]

37. Jiang L, Stuart-Tilley A, Parkash J, Alper SL. pHi and serum regulate AE2-mediated Cl-/HCO3- exchange in CHOP cells of defined transient transfection status. Am J Physiol. 1994;267(Cell Physiol 36):C845–C856.

38. Boyarsky G, Ganz MB, Sterzel RB, Boron WF. pH regulation in single mesangial cells II: Na+-dependent and -independent Cl-/HCO3- exchangers. Am J Physiol. 1988;255(Cell Physiol 24):C857–C869.

39. Talukder MAH, Endoh M. Pharmacological differentiation of synergistic contribution of L-type Ca2+ channels and Na+/H+ exchange to the positive inotropic effect of phenylephrine, endothelin-3 and angiotensin II in rabbit ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:87–96.[Medline] [Order article via Infotrieve]

40. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Mizuno T, Takano H, Hiroi Y, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. Angiotensin II partly mediates mechanical stress–induced cardiac hypertrophy. Circ Res. 1995;77:258–265.[Abstract/Free Full Text]

41. Ito N, Kagaya Y, Weinberg EO, Barry WH, Lorell BH. Endothelin and angiotensin II stimulation of Na+/H+ exchange is impaired in cardiac hypertrophy. J Clin Invest. 1997;99:125–135.[Medline] [Order article via Infotrieve]

42. Wallert MA, Frolich O. Na+/H+ exchange in isolated myocytes from adult rat heart. Am J Physiol. 1989;257(Cell Physiol 26):C207–C213.

43. Korichneva I, Pucéat M, Cassoly R, Vassort G. Cl-/HCO3- exchange in developing neonatal rat cardiac cells: biochemical identification and immunolocalization of band 3–like proteins. Circ Res. 1995;77:556–564.[Abstract/Free Full Text]

44. Simchowitz L, Roos A. Regulation of intracellular pH in human neutrophils. J Gen Physiol. 1985;85:443–470.[Abstract/Free Full Text]

45. de Gasparo M, Husain A, Alexander W, Cat KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T, Timmermans PBMWM. Proposed update of angiotensin receptor nomenclature. Hypertension. 1995;25:924–927.[Free Full Text]

46. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991;88:921–933.

47. Sadoshima J, Zhihua Q, Morgan JP, Izumo S. Angiotensin II and other hypertrophic stimuli mediated by G protein–coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes: the critical role of Ca2+-dependent signaling. Circ Res. 1995;76:1–15.[Abstract/Free Full Text]

48. Kudrycki KE, Newman PR, Shull GE. cDNA cloning and tissue distribution of mRNAs for two proteins that are related to band 3 Cl-/HCO3- exchanger. J Biol Chem. 1990;265:462–471.[Abstract/Free Full Text]

49. Yannoukakos D, Stuart-Tilley A, Fernandez HA, Fey P, Duyk G, Alper SL. Molecular cloning, expression, and chromosomal localization of two isoforms of the AE3 anion exchanger from human heart. Circ Res. 1994;75:603–614.[Abstract/Free Full Text]

50. Ludt J, Tønnessen TI, Sandvig K, Olsnes S. Evidence for involvement of protein kinase C in regulation of intracellular pH by Cl-/HCO3- antiport. J Membr Biol. 1991;119:179–186.[Medline] [Order article via Infotrieve]

51. Grace AA, Vanderberg JI. Angiotensin II enhances cardiac pHi regulation in the presence of HCO3- via three acid-base transport mechanisms. Circulation. 1993;88(suppl I):I-331. Abstract.

52. Cabantchik ZA, Knauf PA, Rothstein A. The anion transport system of the red blood cell: the role of membrane protein evaluated by the use of `probes.' Biochim Biophys Acta. 1978;515:239–302.[Medline] [Order article via Infotrieve]

53. Grinstein S, Rothstein A, Sarkadi B, Gelfand EW. Responses of lymphocytes to anisotonic media: volume-regulating behavior. Am J Physiol. 1984;246(Cell Physiol 15):C204–C215.

54. Aickin CC, Braidin AF. The role of chloride-bicarbonate exchange in the regulation of intracellular chloride in guinea-pig vas deferens. J Physiol (Lond).. 1984;349:587–606.[Abstract/Free Full Text]

55. Hume JR, Harvey RD. Chloride conductance pathways in heart. Am J Physiol. 1991;261(Cell Physiol 30):C399–C412.

56. Morita H, Kimura J, Endoh M. Angiotensin II activation of a chloride current in rabbit cardiac myocytes. J Physiol (Lond). 1995;483:119–130.[Abstract/Free Full Text]

57. Ikenouchi I, Barry JH, Bridge JHB, Weinberg EO, Apstein CS, Lorell BH. Effects of angiotensin II on intracellular Ca2+ and pH in isolated beating rabbit hearts and myocytes loaded with the indicator indo-1. J Physiol (Lond). 1994;480:203–215.[Abstract/Free Full Text]

58. Fujita S, Endoh M. Effects of endothelin-1 on [Ca2+]i-shortening trajectory and Ca2+ sensitivity in rabbit single ventricular cardiomyocytes loaded with indo-1/AM: comparison with the effects of phenylephrine and angiotensin II. J Card Fail. 1996;2:S45–S57.[Medline] [Order article via Infotrieve]

59. Moolenaar WH, Tsien RY, Van deer Saag PT, de Laat SW. Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts. Nature. 1983;304:645–648.[Medline] [Order article via Infotrieve]

60. Rothenberg P, Glaser L, Schlesinger P, Cassel D. Activation of Na+/H+ exchange by epidermal growth factor elevates intracellular pH in A431 cells. J Biol Chem. 1983;258:12644–12653.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
V. Prasad, I. Bodi, J. W. Meyer, Y. Wang, M. Ashraf, S. J. Engle, T. Doetschman, K. Sisco, M. L. Nieman, M. L. Miller, et al.
Impaired Cardiac Contractility in Mice Lacking Both the AE3 Formula Exchanger and the NKCC1 Na+-K+-2Cl- Cotransporter: EFFECTS ON Ca2+ HANDLING AND PROTEIN PHOSPHATASES
J. Biol. Chem., November 14, 2008; 283(46): 31303 - 31314.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. E. Cingolani and I. L. Ennis
Sodium-Hydrogen Exchanger, Cardiac Overload, and Myocardial Hypertrophy
Circulation, March 6, 2007; 115(9): 1090 - 1100.
[Full Text] [PDF]


Home page
HypertensionHome page
H. E. Cingolani, M. C. Villa-Abrille, M. Cornelli, A. Nolly, I. L. Ennis, C. Garciarena, A. M. Suburo, V. Torbidoni, M. V. Correa, M. C. Camilionde Hurtado, et al.
The Positive Inotropic Effect of Angiotensin II: Role of Endothelin-1 and Reactive Oxygen Species
Hypertension, April 1, 2006; 47(4): 727 - 734.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Palomeque, L. Sapia, R. J. Hajjar, A. Mattiazzi, and M. Vila Petroff
Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H96 - H106.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. V Alvarez, D. M Kieller, A. L Quon, D. Markovich, and J. R Casey
Slc26a6: a cardiac chloride-hydroxyl exchanger and predominant chloride-bicarbonate exchanger of the mouse heart
J. Physiol., December 15, 2004; 561(3): 721 - 734.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. G Perez, M. C Villa-Abrille, E. A Aiello, R. A Dulce, H. E Cingolani, and M. C Camilion de Hurtado
A low dose of angiotensin II increases inotropism through activation of reverse Na+/Ca2+ exchange by endothelin release
Cardiovasc Res, December 1, 2003; 60(3): 589 - 597.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. E. Cingolani, G. E. Chiappe, I. L. Ennis, P. G. Morgan, B. V. Alvarez, J. R. Casey, R. A. Dulce, N. G. Perez, and M. C. Camilion de Hurtado
Influence of Na+-Independent Cl--HCO3- Exchange on the Slow Force Response to Myocardial Stretch
Circ. Res., November 28, 2003; 93(11): 1082 - 1088.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. E Cingolani, N. G Perez, B. Pieske, D. von Lewinski, and M. C Camilion de Hurtado
Stretch-elicited Na+/H+ exchanger activation: the autocrine/paracrine loop and its mechanical counterpart
Cardiovasc Res, March 15, 2003; 57(4): 953 - 960.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. E. Cingolani and M. C. Camilion de Hurtado
Na+-H+ Exchanger Inhibition: A New Antihypertrophic Tool
Circ. Res., April 19, 2002; 90(7): 751 - 753.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. C. Camilion de Hurtado, E. L. Portiansky, N. G. Perez, O. R. Rebolledo, and H. E. Cingolani
Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na+/H+ exchanger
Cardiovasc Res, March 1, 2002; 53(4): 862 - 868.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Chiappe de Cingolani, P. Morgan, C. Mundina-Weilenmann, J. Casey, J. Fujinaga, M. Camilion de Hurtado, and H. Cingolani
Hyperactivity and altered mRNA isoform expression of the Cl-/HCO3- anion-exchanger in the hypertrophied myocardium
Cardiovasc Res, July 1, 2001; 51(1): 71 - 79.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. G. Perez, M. C. C. de Hurtado, and H. E. Cingolani
Reverse Mode of the Na+-Ca2+ Exchange After Myocardial Stretch : Underlying Mechanism of the Slow Force Response
Circ. Res., March 2, 2001; 88(4): 376 - 382.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Papageorgiou, B. E. Shmukler, A. K. Stuart-Tilley, L. Jiang, and S. L. Alper
AE anion exchangers in atrial tumor cells
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H937 - H945.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. G V. Petroff, E. A Aiello, J. Palomeque, M. A Salas, and A. Mattiazzi
Subcellular mechanisms of the positive inotropic effect of angiotensin II in cat myocardium
J. Physiol., November 15, 2000; 529(1): 189 - 203.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. C. C. de Hurtado, B. V. Alvarez, I. L. Ennis, and H. E. Cingolani
Stimulation of Myocardial Na+-Independent Cl--HCO3- Exchanger by Angiotensin II Is Mediated by Endogenous Endothelin
Circ. Res., March 31, 2000; 86(6): 622 - 627.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. E. Cingolani
Na+/H+ exchange hyperactivity and myocardial hypertrophy: Are they linked phenomena?
Cardiovasc Res, December 1, 1999; 44(3): 462 - 467.
[Full Text] [PDF]


Home page
Circ. Res.Home page
B. V. Alvarez, N. G. Perez, I. L. Ennis, M. C. Camilion de Hurtado, and H. E. Cingolani
Mechanisms Underlying the Increase in Force and Ca2+ Transient That Follow Stretch of Cardiac Muscle : A Possible Explanation of the Anrep Effect
Circ. Res., October 15, 1999; 85(8): 716 - 722.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. L. Skolnick, S. E. Litwin, W. H. Barry, and K. W. Spitzer
Effect of ANG II on pHi, [Ca2+]i, and contraction in rabbit ventricular myocytes from infarcted hearts
Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1788 - H1797.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. E. Cingolani, B. V. Alvarez, I. L. Ennis, and M. C. Camilion de Hurtado
Stretch-Induced Alkalinization of Feline Papillary Muscle : An Autocrine-Paracrine System
Circ. Res., October 19, 1998; 83(8): 775 - 780.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. V. Alvarez, J. Fujinaga, and J. R. Casey
Molecular Basis for Angiotensin II-Induced Increase of Chloride/Bicarbonate Exchange in the Myocardium
Circ. Res., December 7, 2001; 89(12): 1246 - 1253.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Hurtado, M. C. C.
Right arrow Articles by Cingolani, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Hurtado, M. C. C.
Right arrow Articles by Cingolani, H. E.